Derivation and definitions of clinical study variables for multiple long term conditions in patients with chronic obstructive pulmonary disease: Protocol for a modified Delphi methods and consensus study on behalf of the International Cardiovascular and Respiratory Alliance
Joseph, T., Bhutani, M., Couper, A., Pullen, R., Nadarajah, R., Alves, L., Montero-Arias, M. F., Al-Lehebi, R., Berg, D., Hawkins, N. M., Hurst, J. R., Jenkins, C., Kaplan, A., Kocks, J. W., Kostikas, K., Lam, C. S., Lapperre, T. S., Rhee, C. K., Sattar, N., Stolz, D., Tse, G., Winders, T. A., Price, D., Gale, C. P.
Pragmatic and Observational Research, vol. 16, pp. 243—251
Contributions to Journals: Articles
[ONLINE] DOI:
[OPEN ACCESS]
CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment: Therapeutic Advances in Respiratory Disease
Therapeutic advances in respiratory disease, vol. 19, 17534666251329192
Contributions to Journals: Articles
[ONLINE] DOI:
[OPEN ACCESS]
Economic burden of asthma multimorbidity in Singapore: Shadow costs of steroid use
Lim, L. H. M., Juang, Y. R., Chotirmall, S. H., Tan, K. B., Koh, M. S., Abisheganaden, J. A., Price, D. B., Tsai, M., Liew, M. F., Tiew, P. Y., Yii, A. C. A., Chen, W.
World Allergy Organization Journal, vol. 18, no. 12, 101146
Contributions to Journals: Articles
[ONLINE]
[ONLINE] DOI:
[OPEN ACCESS]
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approach
Wang, E., Henley, W., Larenas-Linnemann, D., Bulathsinhala, L., Tran, T. N., Wechsler, M. E., Aaron, S. D., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Barker, P., Beastall, A., Belevskiy, A. S., Bergeron, C., Bjermer, L., Björnsdóttir, U. S., Bosnic-Anticevich, S. Z., Bourdin, A., Brusselle, G. G., Busby, J., Canonica, G. W., Carter, V., Chapman, K. R., Chapman, N., Christoff, G. C., Cosio, B. G., Costello, R. W., Fingleton, J., Fonseca, J. A., Gaga, M., Gibson, P. G., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Horiguchi, T., Hoyte, F., Hubbard, R. B., Iwanaga, T., Jackson, D. J., Katial, R., Koh, M. S., Kostikas, K., Kuna, P., Lehmann, S., Lehtimäki, L., Louis, R., Lúdvíksdóttir, D., Lugogo, N., Mahboub, B., Martin, N., Máspero, J., Menzies-Gow, A. N., Mohan, A., Murray, R. B., Nagano, T., Papadopoulos, N. G., Papaioannou, A. I., Patel, P. H., Perez-de-Llano, L., Perng, D., Peters, M. J., Pfeffer, P. E., Pitrez, P. M., Pleasants, R. A., Popov, T. A., Porsbjerg, C. M., Puggioni, F., Quinton, A., Rhee, C. K., Sadatsafavi, M., Salvi, S., Scioscia, G., Sheu, C., Sirena, C., Taillé, C., Taube, C., Torres-Duque, C. A., Tsai, M., Tunsäter, A., Ulrik, C. S., Price, D. B.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 13, no. 12, pp. 3296-3315
Contributions to Journals: Articles
[ONLINE] DOI:
[OPEN ACCESS]
Are adults with COPD in Australian primary care at a greater risk of cardiovascular events than adults without COPD?
Wiseman, R., Hew, M., Ko, B., Jenkins, C., Cochrane,, B., Thompson, P. J., Hancock, K. L., McDonald, V., Leong, P., Tyrer, F., Le Cheng, P., Le Lievre, C. E., Roussos, A., Dickens, A. P., Evans, A., Bushell, N., Botini, F., Carter, V., Catanzariti, A., Bosnic-Anticevich, S. Z., Novic, D., Perret, J., Ranasinghe, K., Sharma, A., Stewart, D., Le, T., Price, D.
The ERS Congress 2025, PA1398
Contributions to Journals: Abstracts
[ONLINE] DOI:
A time-clocked care pathway on severe asthma: A global consensus by Delphi methodology
Bhutani, M., Winders, T. A., Price, D., Canonica, G. W., Van Veen, J. A., Kupczyk, M., Evans, A., Patel, S., Kocks, J. W. H.
The ERS Congress 2025, PA1414
Contributions to Journals: Abstracts
[ONLINE] DOI:
Clinical profile of severe asthma (SA) patients Mexican vs Global data and evolution once in the international severe asthma registry (ISAR)
Larenas-Linnemann, D., Cerda-Reyes, S., García-Ramírez, U., Castillón-Benavides, N., Contreras Contreras, E. A., Barboa, L., Aguilar-Hinojosa, N., Rivera-Alvarado, K., Ochoa-García, I. V., Azuara-Trujillo, H., Navarrete-Rodríguez, E., Jiménez-Carrillo, C., Mendoza Reyna, L. D., Friston, D., Scelo, G., Price, D.
The ERS Congress 2025, PA5707
Contributions to Journals: Abstracts
[ONLINE] DOI:
Extrafine beclometasone/formoterol is non-inferior to budesonide/formoterol as maintenance and reliever therapy (MART) for adult asthma patients and reduces the total carbon footprint of all inhaler-related greenhouse gas (GHG) emissions
Jenkins, C., Ramakrishnan, S., Farah, C., Crooks, M., Tyrer, F., Pathak, S., Roussos, A., Ariti, C., Townend, J., Ravi, R., Tham, M., Carter, V., Bardin, P. G., Wark, P. A., Price, D.
The ERS Congress 2025, PA342
Contributions to Journals: Abstracts
[ONLINE] DOI:
Long-term exacerbation trends before/after initiating triple therapy for uncontrolled asthma
Roche, N., Brusselle, G., Gayle, A., Di Palma, L., Piraino, A., Scaffidi-Argentina, U., Grainge, C., Singh, D., Carter, V., Shi Kai Chan, J., Henley, W., Neil, D., Skinner, D., Streeter, A., Price, D.
The ERS Congress 2025, PA4637
Contributions to Journals: Abstracts
[ONLINE] DOI:
Modelling the impact of earlier biologic initiation in severe asthma patients
Couillard, S., Lugogo, N., Winders, T. A., Bhutani, M., Bates, L., Robinson, E., Evans, A., Patel, S., Gibson, D., Price, D.
